Announcements Trials

Browse Landscape

Status

Completed 9 Recruiting 3 Unknown 2 Withdrawn 1 Not yet recruiting 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gastrointestinal 1 Breast 1

Conditions

Esophageal Neoplasms 1

Interventions

Oxaliplatin 95 Fluorouracil 84 Capecitabine 75 Gemcitabine 72 Leucovorin 68 Nivolumab 67 Bevacizumab 63 pembrolizumab 60 Magnetic Resonance Spectroscopy 52 Specimen Handling 50 Irinotecan 50 durvalumab 46 Radiotherapy 42 atezolizumab 40 Cisplatin 39 Paclitaxel 37 Biopsy 37 130-nm albumin-bound paclitaxel 34 Cetuximab 29 Carboplatin 27 Albumin-Bound Paclitaxel 26 Taxes 24 Drug Therapy 20 dehydroftorafur 19 Radiation 19 Ipilimumab 19 tislelizumab 18 Surgical Procedures, Operative 17 Standard of Care 17 Docetaxel 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Mass Screening × Gastrointestinal × Clear all

NCT06335966 2026-03-17

BEST-RPP

OHSU Knight Cancer Institute

Active not recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡